利润表（恩华药业）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 4,145,463,113.62 | 2,763,398,107.90 | 1,357,565,651.12 | 5,041,504,467.27 | 3,655,985,179.26 | 2,400,328,791.85 | 1,178,806,488.43 |
| 营业收入(元) | 4,145,463,113.62 | 2,763,398,107.90 | 1,357,565,651.12 | 5,041,504,467.27 | 3,655,985,179.26 | 2,400,328,791.85 | 1,178,806,488.43 |
| 二、营业总成本(元) | 2,995,908,599.95 | 2,034,082,887.88 | 1,036,808,322.12 | 3,912,018,753.63 | 2,660,054,429.07 | 1,774,122,216.02 | 909,691,076.33 |
| 营业成本(元) | 1,088,072,577.17 | 759,967,077.35 | 396,706,892.37 | 1,369,843,092.52 | 983,158,637.28 | 630,181,270.64 | 314,403,655.18 |
| 研发费用(元) | 435,669,866.92 | 301,501,378.31 | 143,419,925.68 | 549,316,314.71 | 384,712,055.91 | 237,783,256.56 | 109,676,566.12 |
| 营业税金及附加(元) | 54,093,907.54 | 36,781,715.10 | 18,671,853.05 | 68,000,425.86 | 49,281,900.34 | 32,979,020.76 | 16,761,397.77 |
| 销售费用(元) | 1,251,569,944.16 | 829,721,751.03 | 437,028,082.70 | 1,737,004,116.53 | 1,101,292,675.96 | 782,565,128.06 | 420,690,790.82 |
| 管理费用(元) | 178,668,886.12 | 114,894,739.91 | 47,337,294.88 | 207,115,733.15 | 151,536,044.45 | 94,609,546.23 | 50,680,200.35 |
| 财务费用(元) | -12,166,581.96 | -8,783,773.82 | -6,355,726.56 | -19,260,929.14 | -9,926,884.87 | -3,996,006.23 | -2,521,533.91 |
| 其中：利息费用(元) | 3,215,924.43 | 2,342,331.06 | 1,185,818.71 | 4,163,660.59 | 3,188,980.18 | 2,281,372.05 | 460,236.09 |
| 其中：利息收入(元) | 16,196,021.76 | 11,591,935.22 | 8,087,193.12 | 23,810,092.97 | 13,855,152.22 | 6,640,869.53 | 3,901,362.75 |
| 三、其他经营收益 | |||||||
| 加：投资收益(元) | 43,375,987.19 | 20,851,926.82 | 11,387,148.34 | 51,043,519.71 | 37,313,681.10 | 25,240,612.99 | 15,867,492.31 |
| 其中：对联营企业和合营企业的投资收益(元) | 6,849,364.25 | 3,430,270.81 | 4,217,116.53 | 9,639,849.09 | 5,402,534.07 | 1,458,406.22 | 5,138,559.22 |
| 资产处置收益(元) | 30,193.71 | 28,993.71 | -1,350.23 | 147,225.37 | -215,578.30 | 30,343.10 | 30,343.10 |
| 资产减值损失(元) | -12,323,134.97 | -6,600,248.89 | -6,402,166.22 | -33,269,425.33 | -19,252,233.13 | -11,576,802.26 | -7,938,681.09 |
| 信用减值损失(元) | -16,040,020.85 | -16,646,330.25 | -23,716,780.68 | -15,108,030.51 | -13,437,978.90 | -17,289,395.88 | -16,664,681.66 |
| 其他收益(元) | 6,795,906.62 | 5,604,216.96 | 2,847,100.63 | 50,045,165.10 | 5,118,234.86 | 3,480,710.64 | 1,169,674.25 |
| 四、营业利润(元) | 1,171,393,445.37 | 732,553,778.37 | 304,871,280.84 | 1,182,344,167.98 | 1,005,456,875.82 | 626,092,044.42 | 261,579,559.01 |
| 加：营业外收入(元) | 2,560,181.44 | 1,844,063.19 | 1,822,817.08 | 6,747,213.27 | 635,758.79 | -122,091.80 | -1,022,267.57 |
| 减：营业外支出(元) | 21,555,368.93 | 13,405,372.02 | 6,957,950.82 | 20,447,283.64 | 5,317,794.92 | 3,980,171.31 | 2,057,581.29 |
| 五、利润总额(元) | 1,152,398,257.88 | 720,992,469.54 | 299,736,147.10 | 1,168,644,097.61 | 1,000,774,839.69 | 621,989,781.31 | 258,499,710.15 |
| 减：所得税费用(元) | 135,861,062.07 | 94,418,917.04 | 35,097,370.69 | 134,396,810.10 | 117,360,174.35 | 77,581,388.33 | 33,326,313.96 |
| 六、净利润(元) | 1,016,537,195.81 | 626,573,552.50 | 264,638,776.41 | 1,034,247,287.51 | 883,414,665.34 | 544,408,392.98 | 225,173,396.19 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 1,016,537,195.81 | 626,573,552.50 | 264,638,776.41 | 1,034,247,287.51 | - | 544,408,392.98 | - |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 1,020,107,123.07 | 628,920,268.32 | 265,282,248.03 | 1,036,918,058.61 | 885,641,307.43 | 544,703,014.00 | 227,429,413.46 |
| 少数股东损益(元) | -3,569,927.26 | -2,346,715.82 | -643,471.62 | -2,670,771.10 | -2,226,642.09 | -294,621.02 | -2,256,017.27 |
| 扣除非经常性损益后的净利润(元) | 1,030,463,807.91 | 633,975,167.46 | 267,286,357.38 | 1,013,075,096.44 | 885,663,368.14 | 545,255,389.06 | 229,200,150.71 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 1.01 | 0.62 | 0.26 | 1.03 | 0.88 | 0.54 | 0.23 |
| 二、稀释每股收益(元) | 1.01 | 0.62 | 0.26 | 1.03 | 0.88 | 0.54 | 0.23 |
| 八、其他综合收益(元) | - | - | - | -6,348,894.40 | - | - | - |
| 归属于母公司股东的其他综合收益(元) | - | - | - | -6,348,894.40 | - | - | - |
| 九、综合收益总额(元) | 1,016,537,195.81 | 626,573,552.50 | 264,638,776.41 | 1,027,898,393.11 | 883,414,665.34 | 544,408,392.98 | 225,173,396.19 |
| 归属于母公司所有者的综合收益总额(元) | 1,020,107,123.07 | 628,920,268.32 | 265,282,248.03 | 1,030,569,164.21 | 885,641,307.43 | 544,703,014.00 | 227,429,413.46 |
| 归属于少数股东的综合收益总额(元) | -3,569,927.26 | -2,346,715.82 | -643,471.62 | -2,670,771.10 | -2,226,642.09 | -294,621.02 | -2,256,017.27 |
| 公告日期 | 2024-10-26 | 2024-07-31 | 2024-04-20 | 2024-03-30 | 2023-10-26 | 2023-07-31 | 2023-04-14 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 43 of 43 entries